| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-13 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-13 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
3e-12 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-11 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-11 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-11 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-11 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-11 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-10 |